The latest quarterly R&D expense is $21.93 Million with a QoQ Growth of +13.53%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $21.93M.
$21.93M
$21.93 Million
Q2 FY2026 · 2026-06-30
+13.53%
vs. $19.31M prior quarter
14
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $21.93M | +13.53% | +22.75% |
| Q1 FY2026Period end 2026-03-31 | $19.31M | +13.64% | +13.25% |
| Q4 FY2025Period end 2025-12-31 | $16.99M | -3.62% | +27.61% |
| Q3 FY2025Period end 2025-09-30 | $17.63M | -1.28% | +30.38% |
| Q2 FY2025Period end 2025-06-30 | $17.86M | +4.74% | +44.82% |
| Q1 FY2025Period end 2025-03-31 | $17.05M | +28.05% | +52.85% |
| Q4 FY2024Period end 2024-12-31 | $13.32M | -1.53% | +19.40% |
| Q3 FY2024Period end 2024-09-30 | $13.52M | +9.66% | +3.51% |
| Q2 FY2024Period end 2024-06-30 | $12.33M | +10.55% | +9.51% |
| Q1 FY2024Period end 2024-03-31 | $11.16M | +0.03% | -24.47% |
| Q4 FY2023Period end 2023-12-31 | $11.15M | -14.63% | N/A |
| Q3 FY2023Period end 2023-09-30 | $13.06M | +16.01% | N/A |
| Q2 FY2023Period end 2023-06-30 | $11.26M | -23.76% | N/A |
| Q1 FY2023Period end 2023-03-31 | $14.77M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
